Eli Lilly And Company Political Action Committee SEP MONTHLY Filings
| Cycle | Date Filed | End Date | Amendment | Receipts | Spending | Cash |
|---|---|---|---|---|---|---|
| 2024 | Sept. 19, 2023 | Aug. 31, 2023 | $98,640.45 | $81,250.00 | $1,438,298.35 | |
| 2022 | Sept. 14, 2022 | Aug. 31, 2022 | $81,905.46 | $101,900.00 | $1,144,533.54 | |
| 2022 | Sept. 20, 2021 | Aug. 31, 2021 | $81,057.72 | $60,300.00 | $1,146,534.54 | |
| 2020 | Sept. 17, 2020 | Aug. 31, 2020 | $85,223.01 | $98,500.00 | $810,237.29 | |
| 2020 | Sept. 13, 2019 | Aug. 31, 2019 | $85,661.03 | $19,320.00 | $413,052.53 | |
| 2018 | Sept. 18, 2018 | Aug. 31, 2018 | $73,805.10 | $176,850.00 | $261,104.78 | |
| 2018 | Sept. 20, 2017 | Aug. 31, 2017 | $80,556.34 | $33,700.00 | $453,946.80 | |
| 2016 | Sept. 19, 2016 | Aug. 31, 2016 | $85,010.74 | $65,600.00 | $644,260.20 | |
| 2016 | Sept. 17, 2015 | Aug. 31, 2015 | $81,147.13 | $83,650.00 | $884,402.23 | |
| 2014 | Sept. 15, 2014 | Aug. 31, 2014 | $84,222.44 | $132,600.00 | $997,553.09 | |
| 2014 | Sept. 19, 2013 | Aug. 31, 2013 | $90,518.07 | $110,200.00 | $1,106,071.04 | |
| 2012 | Sept. 20, 2012 | Aug. 31, 2012 | $95,536.10 | $150,780.00 | $825,396.85 | |
| 2012 | Sept. 16, 2011 | Aug. 31, 2011 | $94,289.94 | $129,450.00 | $1,025,911.43 | |
| 2010 | Sept. 20, 2010 | Aug. 31, 2010 | $97,740.12 | $123,400.00 | $966,829.04 | |
| 2010 | Sept. 17, 2009 | Aug. 31, 2009 | $94,651.06 | $52,734.79 | $866,222.96 | |
| 2008 | Sept. 18, 2008 | Aug. 31, 2008 | $103,470.51 | $105,700.00 | $736,710.92 | |
| 2008 | Sept. 19, 2007 | Aug. 31, 2007 | $94,443.80 | $57,234.40 | $586,878.00 | |
| 2006 | Sept. 20, 2006 | Aug. 31, 2006 | $89,481.59 | $312,732.57 | $326,427.15 | |
| 2006 | Sept. 15, 2005 | Aug. 31, 2005 | $77,305.50 | $24,950.00 | $487,012.00 | |
| 2004 | Sept. 17, 2004 | Aug. 31, 2004 | View | View | ||
| 2004 | Nov. 19, 2003 | Aug. 31, 2003 | Compare to original | $69,297.20 | $61,150.00 | $290,225.00 |
| 2002 | Sept. 4, 2002 | Aug. 31, 2002 | View | View | ||
| 2002 | Sept. 4, 2001 | Aug. 31, 2001 | View | View |